SOX2 and colorectal cancer: Tests registered for in vitro diagnostics that examine the methylation of promoter regions of various genes in ctDNA (e.g., SEPT9 for colorectal cancer or SOX2 for NSCLC identification) are of limited use in CUP diagnosis due to inadequate sensitivity and low organ specificity [31,75,76].